CPI
Showing 1 - 25 of 334
Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)
Not yet recruiting
- Recurrent Ovarian Cancer
-
Pittsburgh, PennsylvaniaMagee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023
Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)
Not yet recruiting
- Mycosis Fungoides
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 13, 2023
Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500
Recruiting
- Pancreas Adenocarcinoma
- CPI-613® (Dose level -1.0 250 mg/m^2)
- +6 more
-
Detroit, Michigan
- +1 more
Nov 9, 2022
Healthy Trial in Liège (Ir-CPI - Dose 1, Ir-CPI - Dose 2, Ir-CPI - Dose 3)
Active, not recruiting
- Healthy
- Ir-CPI - Dose 1
- +4 more
-
Liège, BelgiumA.T.C. Pharma
Jul 19, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CPI 613
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
May 10, 2023
Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- CPI 613
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Advanced Solid Tumor Trial in Grand Rapids (CPI-200)
Completed
- Advanced Solid Tumor
-
Grand Rapids, MichiganSouth Texas Accelerated Research Therapeutics (START Midwest)
Feb 22, 2022
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- +32 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Feb 6, 2023
Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)
Recruiting
- Sarcoma, Clear Cell
- CPI-613 + Hydroxychloroquine
-
Duarte, California
- +7 more
Nov 10, 2022
Carcinoma, Squamous Cell of Head and Neck, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in United
Terminated
- Carcinoma, Squamous Cell of Head and Neck
- +3 more
- ilixadencel
- Pembrolizumab
-
Coral Gables, Florida
- +4 more
Mar 1, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Autism Spectrum Disorder Trial in Lexington (Parent-based Crisis Prevention Institute (CPI) physical management training program
Completed
- Autism Spectrum Disorder
- Parent-based Crisis Prevention Institute (CPI) physical management training program (P-CPI)
-
Lexington, MassachusettsLurie Center for Autism
Jun 7, 2021
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Active, not recruiting
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +16 more
- 6,8-bis(benzylthio)octanoic acid
- bendamustine hydrochloride
-
Winston-Salem, North Carolina
- +1 more
Apr 8, 2022
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Biliary Tract Cancer Trial in United States (CPI 613, Gemcitabine, Cisplatin)
Recruiting
- Biliary Tract Cancer
- CPI 613
- +2 more
-
Tucson, Arizona
- +9 more
Feb 18, 2022